Drug Trial Radar · NCT05603754
Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (STRIDES)
Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
499
Actual
Start
Nov 18, 2022
Primary completion
Feb 20, 2024
Study completion Feb 20, 2024
Sponsor
- Lead sponsor
- Biosplice Therapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- NBCD A/S
- First posted
- Nov 3, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase 3 study was a multicenter, randomized, double-blind, placebo-controlled study of lorecivivint injected intra-articularly (IA) into the target (most painful) knee joint of moderately to severely symptomatic osteoarthritis (OA) subjects at a single dose of 0.07 mg lorecivivint per 2 mL injection. This study utilized standard outcomes to evaluate the safety and efficacy of lorecivivint.
Conditions
- Knee Osteoarthritis
Interventions
LorecivivintDrug
One intra-articular injection of 0.07 mg lorecivivint in 2 mL vehicle
PlaceboDrug
One intra-articular injection of 0 mg lorecivivint in 2 mL vehicle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline OA Pain in the Target Knee as Assessed by Weekly Average of Daily Pain Numeric Rating Scale (NRS) at Week 12Time frame: Baseline to Week 12
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
Tucson Orthopaedic Institute
Tucson, Arizona
Core Healthcare Research
Cerritos, California
BioSolutions Clinical Research Center
La Mesa, California
Infinity Clinical Research
Norco, California
Dream Team Clinical Research
Pomona, California
Artemis Institute for Clinical Research
San Diego, California
Encompass Clinical Research
Spring Valley, California
Millennium Clinical Trials, LLC
Thousand Oaks, California
Unique Clinical Trials
Doral, Florida
Eastern Research, Inc.
Hialeah, Florida
TecTum Research
Hollywood, Florida
Columbus Clinical Services, LLC
Miami, Florida
AppleMed Research Group, LLC
Miami, Florida
Advance Medical Research Center
Miami, Florida
Health and Life Research Institute, LLC
Miami, Florida
BioMed Research and Medical Center
Miami, Florida
Well Pharma Medical Research, Corp
Miami, Florida
South Florida Research Phase I-IV, Inc.
Miami Springs, Florida
Tampa Pain Relief Center
Tampa, Florida
Premier Medical Associates
The Villages, Florida
Conquest Research, LLC
Winter Park, Florida
Pinnacle Trials, Inc.
Stockbridge, Georgia
Chicago Clinical Research Institute
Chicago, Illinois
MediSphere Medical Research Center, LLC
Evansville, Indiana
DelRicht Research - Mandeville
Mandeville, Louisiana
DelRicht Research
New Orleans, Louisiana
DelRicht Research - Prairieville
Prairieville, Louisiana
DelRicht Research - Rockville
Rockville, Maryland
Skylight Health Research
Burlington, Massachusetts
Oakland Medical Research
Troy, Michigan
Healthcare Research Network
Hazelwood, Missouri
Albuquerque Clinical Trials
Albuquerque, New Mexico
Hightop Medical Research Center
Cincinnati, Ohio
Conrad Clinical Research
Edmond, Oklahoma
DelRicht Research - Tulsa
Tulsa, Oklahoma
Clinical Trials of South Carolina
Charleston, South Carolina
Piedmont Research Partners, LLC
Fort Mill, South Carolina
Health Concepts
Rapid City, South Dakota
Zenos Clinical Research
Dallas, Texas
Synergy Groups Medical, LLC
Houston, Texas
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.